European capnography devices market was valued at $171.0 million in 2025 and is projected to reach $304.0 million by 2035, growing at a CAGR of 6.0% during the forecast period (2026–2035). Capnography devices are critical respiratory monitoring tools used to measure end-tidal carbon dioxide (EtCO?), supporting real-time assessment of ventilation, airway integrity, and metabolic status. These systems are widely deployed across operating rooms, intensive care units (ICUs), emergency departments, procedural sedation settings, and pre-hospital care environments. Market growth is being driven by the rising prevalence of respiratory disorders, increasing surgical and anesthesia procedures, and the growing emphasis on patient safety and continuous respiratory monitoring across European healthcare systems. Additionally, the expanding elderly population, higher incidence of chronic conditions such as COPD and sleep apnea, and stricter clinical guidelines mandating capnography use during sedation and critical care are accelerating adoption. Technological advancements including portable and handheld capnographs, integrated multiparameter monitors, and enhanced waveform analysis—are further improving clinical outcomes and workflow efficiency.
Browse the full report description of “European Capnography Devices Market Size, Share & Trends Analysis Report by Product Type (Handheld, Standalone, Multiparameter, and Others), By Application (Respiratory Disease, Cardiology, Trauma & Emergency, and Others), By End-User (Hospital & Clinics and Ambulatory Surgical Centers) Forecast Period, (2026-2035)” of https://www.omrglobal.com/industry-reports/europe-capnography-devices-market
Key trends shaping the European capnography landscape include greater integration with multiparameter patient monitoring platforms, increased use in non-intubated and procedural sedation settings, and growing adoption in ambulatory surgical centers and emergency medical services (EMS).
According to the National Library of Medicine (PubMed Central, PMC), a growing body of peer-reviewed clinical evidence underscores the critical role of continuous respiratory monitoring in managing patients with acute and chronic respiratory conditions, during procedural sedation, anesthesia, and critical care. PMC-indexed studies consistently demonstrate that capnography enables earlier detection of hypoventilation, apnea, and respiratory depression compared with conventional monitoring methods such as pulse oximetry. These findings suggest that as healthcare systems increasingly adopt evidence-based monitoring standards and strengthen safety protocols, the clinical utilization of capnography is expected to continue expanding across advanced care environments.
Key Innovators Driving European Capnography Devices Transformation
The key players in the European capnography devices market include Drägerwerk AG & Co. KGaA., GE HealthCare Technologies Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc., among others. These companies are actively advancing capnography technologies through innovations in sensor accuracy, device portability, integration with patient monitoring systems, and enhanced clinical decision support.
Market Coverage
Key questions addressed by the report
European Capnography Devices Market Report Segment
By Product Type
By Application
By End-User
European Capnography Devices Market Report Segment by Country
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-capnography-devices-market